Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Food Chem Toxicol ; 145: 111702, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-733854

ABSTRACT

Our surrounding environment, especially often-touched contaminated surfaces, plays an important role in the transmission of pathogens in society. The shortage of effective sanitizing fluids, however, became a global challenge quickly after the coronavirus disease-19 (COVID-19) outbreak in December 2019. In this study, we present the effect of surfactants on coronavirus (SARS-CoV-2) virucidal efficiency in sanitizing fluids. Sodium dodecylbenzenesulfonate (SDBS), sodium laureth sulfate (SLS), and two commercial dish soap and liquid hand soap were studied with the goal of evaporation rate reduction in sanitizing liquids to maximize surface contact time. Twelve fluids with different recipes composed of ethanol, isopropanol, SDBS, SLS, glycerin, and water of standardized hardness (WSH) were tested for their evaporation time and virucidal efficiency. Evaporation time increased by 17-63% when surfactant agents were added to the liquid. In addition, surfactant incorporation enhanced the virucidal efficiency between 15 and 27% according to the 4-field test in the EN 16615:2015 European Standard method. Most importantly, however, we found that surfactant addition provides a synergistic effect with alcohols to inactivate the SARS-CoV-2 virus. This study provides a simple, yet effective solution to improve the virucidal efficiency of commonly used sanitizers.


Subject(s)
Antiviral Agents/pharmacology , Betacoronavirus/drug effects , Coronavirus Infections/prevention & control , Hand Sanitizers/pharmacology , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Soaps/pharmacology , Surface-Active Agents/pharmacology , 2-Propanol/pharmacology , A549 Cells , Benzenesulfonates/pharmacology , COVID-19 , Drug Synergism , Ethanol/pharmacology , Glycerol/pharmacology , Humans , SARS-CoV-2 , Sodium Dodecyl Sulfate/analogs & derivatives , Sodium Dodecyl Sulfate/pharmacology , Volatilization/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL